Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression [Internet].

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan.

2.

Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Gaynes BN, Thieda P, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec.

3.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
4.

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G.

Depress Anxiety. 2012 Jun;29(6):495-505. doi: 10.1002/da.21951. Epub 2012 May 2. Review.

PMID:
22553134
5.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
6.

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C.

Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5. Review.

PMID:
19185342
7.

Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.

Khoo AL, Zhou HJ, Teng M, Lin L, Zhao YJ, Soh LB, Mok YM, Lim BP, Gwee KP.

CNS Drugs. 2015 Aug;29(8):695-712. doi: 10.1007/s40263-015-0267-6. Review.

PMID:
26293743
8.

Smoking and antidepressants pharmacokinetics: a systematic review.

Oliveira P, Ribeiro J, Donato H, Madeira N.

Ann Gen Psychiatry. 2017 Mar 6;16:17. doi: 10.1186/s12991-017-0140-8. eCollection 2017. Review.

9.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
10.

Duloxetine versus other anti-depressive agents for depression.

Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD006533. doi: 10.1002/14651858.CD006533.pub2. Review.

11.
12.

Escitalopram: a pharmacoeconomic review of its use in depression.

Croom KF, Plosker GL.

Pharmacoeconomics. 2003;21(16):1185-209. Review.

PMID:
14594439
13.

Spotlight on the pharmacoeconomics of escitalopram in depression.

Croom KF, Plosker GL.

CNS Drugs. 2004;18(7):469-73. Review.

PMID:
15139801
14.

Escitalopram: a review of its use in the management of major depressive disorder in adults.

Garnock-Jones KP, McCormack PL.

CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. Review.

PMID:
20806989
15.

Differential pharmacology of newer antidepressants.

DeVane CL.

J Clin Psychiatry. 1998;59 Suppl 20:85-93. Review.

16.

[Efficacy of escitalopram and severity of depression: new data].

Spadone C.

Encephale. 2009 Dec;35(6):577-85. doi: 10.1016/j.encep.2009.10.004. Review. French.

PMID:
20004289
17.

Liver injury associated with antidepressants.

Park SH, Ishino R.

Curr Drug Saf. 2013 Jul;8(3):207-23. Review.

PMID:
23914755
18.
19.

Citalopram versus other anti-depressive agents for depression.

Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A, Churchill R, Watanabe N, Barbui C.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD006534. doi: 10.1002/14651858.CD006534.pub2. Review.

20.

Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics.

Hill L, Lee KC.

Ann Pharmacother. 2013 Jan;47(1):75-89. doi: 10.1345/aph.1R343. Epub 2013 Jan 22. Review.

PMID:
23341158

Supplemental Content

Support Center